CBDa as a Precursor to CBD: Differences, Effects, and Applications
|
Time to read 5 min
Free delivery on orders over €59 🚚
|
Time to read 5 min
CBD (cannabidiol) has long been an established term in health products and dietary supplements. What many people don't know: CBD is extracted from its precursor CBDa (cannabidiolic acid) through decarboxylation.
Meanwhile, CBDa, as a CBD precursor, is also receiving increasing attention from research, as it has certain, very specific effects of its own.
This article sheds light on the differences between CBD and CBDa, their respective effects and applications, and provides an insight into the state of research on both substances.
CBDa is the acidic precursor of CBD, which in turn is obtained from CBDa through decarboxylation. CBD and CBDa have very different properties and effects.
CBDa is currently receiving increasing attention from science, especially as a highly effective remedy against nausea and vomiting (e.g., as a result of chemotherapy).
Research on CBDa, and thus on possible side effects, is still in its early stages. Pure CBDa oils and other CBDa preparations are currently not available in Germany. Instead, the use of full-spectrum CBD oils, which also contain CBDa and are therefore particularly effective, is recommended.
CBDa (short for cannabidiolic acid) is the acidic precursor of CBD. In the hemp plant, CBD does not initially exist in its known form, but as cannabidiolic acid (CBDa). Through a chemical process (decarboxylation), CBDa is converted into CBD.
During decarboxylation, a carboxyl group (CO2) is split off from the compound by heat or UV light, creating CBD. This process is also referred to as "activating" CBDa, which is why CBDa is also considered "inactive" CBD.
Property |
CBDa |
CBD |
|---|---|---|
Chemical structure |
Contains a carboxyl group |
No carboxyl group |
Stability |
Decomposes when heated |
More stable |
Bioavailability |
Higher in raw form |
Variable (depending on processing) |
High-quality CBD oils from Hanfgeflüster
CBDa and CBD both interact with the endocannabinoid system (ECS), but in different ways. CBD indirectly binds to CB1 and CB2 receptors and interacts with other receptors like TRPV1. CBDa, on the other hand, inhibits specific enzymes and interacts with serotonin receptors (5-HT1A).¹
Even if CBDa is often referred to as "inactive" - it is by no means ineffective! Recent studies show that CBDa has its own unique effects that distinguish it from CBD.
For example, studies¹ have shown the active ingredient to have a strong anti-inflammatory effect. This is due to the inhibition of the enzyme cyclooxygenase-2 (COX-2), which plays a role in inflammation. ² The effectiveness of CBDa in this context appears to be even greater than that of CBD. However, research in this area is still relatively new, and the efficacy of CBD is much better documented.
Additionally, CBDa shows promising results in the treatment of nausea and vomiting, presumably because it influences serotonin receptors. ³
While CBD also reduces the sensation of nausea, CBDa has proven to be more potent in studies. However, CBDa in concentrated form, as used in animal and human studies, is not available to the general public. Instead, we recommend using full-spectrum CBD oils, which contain the full plant spectrum of the hemp plant and thus offer the full potential of its effectiveness.
Overall, CBD has a much broader spectrum of effects than CBDa. Through its interaction with the endocannabinoid system, it has pain-relieving effects, helps regulate anxiety and stress, inhibits inflammation, nausea/vomiting, and improves sleep duration and quality. It is therefore now quite routinely used to treat anxiety, sleep problems, chronic pain, and even epilepsy. In addition, CBD positively affects the immune system through its antioxidant properties.
Effect |
CBDa |
CBD |
|---|---|---|
Anti-inflammatory |
Strong due to COX-2 inhibition |
Moderate effect |
Effect on nausea |
Very effective |
Less specific |
Effect on anxiety |
Still little researched |
Well documented |
Medical applications |
First studies show potential |
Broad clinical applications |
In CBD oils and other products, both forms, i.e. both CBDa and CBD, are generally present. In addition, full-spectrum oils contain other cannabinoids that help to enhance the effectiveness of the products.
Nevertheless, you should pay attention to whether your chosen product was produced with a focus on CBD or CBDa + CBD, as the effects can differ accordingly. Even if all CBD oils generally contain certain amounts of CBDa: To achieve the desired effect, CBD should primarily be included.
*Important information / tip
In freely available CBD products, the THC content (also a cannabinoid from the hemp plant) must not exceed certain limits. While in most EU countries, including Germany, a maximum THC content of 0.2% is permitted in CBD products, in Switzerland the THC content can be up to 1%. Although a higher THC content can increase the effectiveness of the product due to the entourage effect, the risk of undesirable psychoactive effects also increases.
The entourage effect can be utilized with full-spectrum oils without any psychoactive effects. These contain only minimal amounts of THC, but CBDa and CBD also interact and can thus enhance the effectiveness.
Pure products focused on CBDa are hardly available in Germany. Since research into the effects of CBDa - and thus the side effects - is still in its infancy, we recommend using high-quality CBD oils instead, e.g. our CBD Classic Spray. In addition to CBD and CBDa, this also contains other cannabinoids and their precursors such as CBG acid (cannabigerolic acid) and CBG, which have their own positive effects. This way, you benefit from all the advantages, but minimize possible side effects.
CBDa is no longer just known as a precursor to CBD, but is increasingly gaining attention as a completely independent active ingredient. However, research in this area is still in its infancy; comprehensive information on side effects and the like is still lacking.
Products that contain as many different cannabinoids as possible and at the same time have a verified low content of psychoactive THC are still the best choice.
High-quality full-spectrum oils enable you to benefit from all the advantages of the various active ingredients and their interaction (entourage effect) while minimizing the risks of undesirable side effects.
Opinions of our customers:
Sources and studies
¹ Bolognini, D., Rock, E. M., Cluny, N. L., Cascio, M. G., Limebeer, C. L., Duncan, M., Stott, C. G., Javid, F. A., Parker, L. A., & Pertwee, R. G. (2013). Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation. British Journal of Pharmacology, 168(6), 1456–1470.
² Takeda, S., Misawa, K., Yamamoto, I., & Watanabe, K. (2008). Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis. Drug Metabolism and Disposition, 36(9), 1917–1921.
³ Rock, E. M., Limebeer, C. L., Pertwee, R. G., Mechoulam, R., & Parker, L. A. (2021). Therapeutic potential of cannabidiol, cannabidiolic acid, and cannabidiolic acid methyl ester as treatments for nausea and vomiting. Cannabis and Cannabinoid Research, 6(4), 266–274.